Inventor · disambiguated record
Hongming Chen
Also filed as: CHEN HONGMING
50 granted patents·24 pending applications·1,380 citations·filing 1997–2024
98Inventor score
Files withUNIV JOHNS HOPKINS21TRANSFORM PHARMACEUTICALS INC13KALA PHARMACEUTICALS INC10CHEN HONGMING4MASSACHUSETTS INST TECHNOLOGY3
Top patents by PatentIndex Score
74 records- 0199US6060082APolymerized liposomes targeted to M cells and useful for oral or mucosal drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted May 9, 2000·541 cites·23 claims
- 0299US6004534ATargeted polymerized liposomes for improved drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 1997·Granted Dec 21, 1999·513 cites·18 claims
- 0398US10993908B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted May 4, 2021·5 cites·21 claims
- 0498US10940108B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Mar 9, 2021·6 cites·17 claims
- 0598US10857096B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Dec 8, 2020·5 cites·17 claims
- 0698US9056057B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·56 cites·28 claims
- 0797US10945948B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Granted Mar 16, 2021·4 cites·21 claims
- 0896US11219597B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 11, 2022·3 cites·30 claims
- 0996US10688045B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2017·Granted Jun 23, 2020·7 cites·91 claims
- 1096US10646437B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted May 12, 2020·7 cites·88 claims
- 1196US10646436B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted May 12, 2020·7 cites·92 claims
- 1296US9827191B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 28, 2017·13 cites·25 claims
- 1394US11596599B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 7, 2023·2 cites·36 claims
- 1492US10864219B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 15, 2020·5 cites·39 claims
- 1592US6919370B2Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereofTRANSFORM PHARMACEUTICALS INC·Filed 2001·Granted Jul 19, 2005·35 cites·28 claims
- 1692US6387397B1Polymerized liposomes targeted to M cells and useful for oral or mucosal drug deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted May 14, 2002·93 cites·37 claims
- 1790US12178920B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Dec 31, 2024·0 cites·15 claims
- 1890US10058511B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 28, 2018·2 cites·40 claims
- 1989US11219596B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 11, 2022·1 cites·30 claims
- 2089US9393213B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·2 cites·28 claims
- 2187US11872318B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2023·Granted Jan 16, 2024·0 cites·22 claims
- 2287US11642317B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2020·Granted May 9, 2023·1 cites·31 claims
- 2385US8133918B2Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their usesZHANG ZHONG·Filed 2008·Granted Mar 13, 2012·7 cites·29 claims
- 2485US6758099B2System and method for optimizing tissue barrier transfer of compoundsTRANSFORM PHARMACEUTICALS INC·Filed 2001·Granted Jul 6, 2004·23 cites·19 claims
- 2584US12115246B2Compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2023·Granted Oct 15, 2024·0 cites·13 claims
- 2684US9737491B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 22, 2017·1 cites·21 claims
- 2783US10481748B2Display panel and display apparatusXIAMEN TIANMA MICRO ELECTRONICS CO LTD·Filed 2017·Granted Nov 19, 2019·2 cites·18 claims
- 2883US9532955B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2016·Granted Jan 3, 2017·1 cites·20 claims
- 2982US7550155B2Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their usesTRANSFORM PHARMACEUTICALS INC·Filed 2004·Granted Jun 23, 2009·14 cites·48 claims
- 3081US10392388B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2017·Granted Aug 27, 2019·2 cites·38 claims
- 3179US10736854B2Nanocrystals, compositions, and methods that aid particle transport in mucusUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 11, 2020·2 cites·37 claims
- 3278US12053881B1Multi-layer operating system and method for mobile robotsCHEN HONGMING·Filed 2024·Granted Aug 6, 2024·0 cites·10 claims
- 3377US10550089B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2017·Granted Feb 4, 2020·1 cites·7 claims
- 3477US2025312910A1Multi-layer operating system and method for mobile robotsCHEN HONGMING·Filed 2024·Application pending·0 cites
- 3576US8362062B2Pharmaceutical compositions with improved dissolutionMCNEIL PPC INC·Filed 2003·Granted Jan 29, 2013·5 cites·15 claims
- 3674US11091487B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·22 claims
- 3774US9637465B23′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-viralsUNIV BRITISH COLUMBIA·Filed 2013·Granted May 2, 2017·2 cites·38 claims
- 3871US2021332048A1Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3969US6852526B2Transdermal assay with magnetic clampTRANSFORM PHARMACEUTICALS INC·Filed 2002·Granted Feb 8, 2005·6 cites·39 claims
- 4069US2021052489A1Particles, compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4167US12240698B1Hook-type handling device, transport equipment and transport methodCHEN HONGMING·Filed 2024·Granted Mar 4, 2025·0 cites·15 claims
- 4267US9393212B2Nanocrystals, compositions, and methods that aid particle transport in mucusKALA PHARMACEUTICALS INC·Filed 2015·Granted Jul 19, 2016·0 cites·31 claims
- 4366US10704844B2Heat exchangerSANHUA HANGZHOU MICRO CHANNEL HEAT EXCHANGER CO LTD·Filed 2016·Granted Jul 7, 2020·1 cites·20 claims
- 4465US10995072B2Inhibitors of protease-activated receptor-2HEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 4, 2021·0 cites·13 claims
- 4563US7915317B2Aqueous 2,6-diisopropylphenol pharmaceutical compositionsTRANSFORM PHARMACEUTICALS INC·Filed 2003·Granted Mar 29, 2011·1 cites·7 claims
- 4662US9725451B2Meropenem derivatives and uses thereofKALA PHARMACEUTICALS INC·Filed 2014·Granted Aug 8, 2017·0 cites·67 claims
- 4762US8270982B2Method, system and equipment for shifting call based on a mobile terminal with the same number and a soft terminalYI ZHIQUAN·Filed 2010·Granted Sep 18, 2012·2 cites·11 claims
- 4861US2018271782A1Particles, compositions and methods for ophthalmic and/or other applicationsUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
- 4960US2013316006A1Particles, compositions and methods for ophthalmic and/or other applicationsKALA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 5060US2013316001A1Particles, compositions and methods for ophthalmic and/or other applicationsKALA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →